Clinical Trial Update: Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (IBCSG-1-98) evaluating cognitive and related psychosocial effects in postmenopausal women with breast cancer receiving hormone therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer, Cognitive/Functional Effects | Phase 3 | Status: COMPLETED